EGFR-targeting as a biological therapy: Understanding Nimotuzumab's clinical effects

Review

Abstract: Current clinical trials of epidermal growth factor receptor (EGFR)-targeted therapies are mostly gui

Palabras claves:

biological therapy, Cancer treatment, eGFR, nimotuzumab, Targeted therapy

Autores:

Garrido G., Moreno E., Pérez R., Tania Crombet

Fuentes:

scopus